Analysis of discrepancies of core needle biopsy and surgical specimens for accurate evaluation of hormonal receptors and epidermal growth factor receptor 2 status of invasive breast cancer patients

Ljiljana Tadic-Latinovic ,
Ljiljana Tadic-Latinovic
Zivka Eri ,
Zivka Eri
Darko Jovic ,
Darko Jovic
Aleksandra Salapura ,
Aleksandra Salapura
Jovan Culum ,
Jovan Culum
Branislava Jakovljevic ,
Branislava Jakovljevic
Ilija Baros ,
Ilija Baros
Slavica Maric
Slavica Maric

Published: 01.12.2015.

Biochemistry

Volume 32, Issue 1 (2016)

pp. 1372-1377;

https://doi.org/10.5937/matmed1601372t

Abstract

Breast cancer is a serious health problem. It is the most common cancer in women. The aim of this study was to estimate the concordance between ER, PR receptor and HER-2 immunohistochemistry assessment scores in pared CNB (core needle biopsy) and surgical specimens. Histological grade, oestrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor-2 (HER2) status were evaluated in a blinded fashion in CNB and in surgical excision specimens. Absolute concordance rate between core needle biopsies and surgical specimens for histological grade was 50% with κ value (0,15) for ER 92% with κ value (0,79), PR 88% with κ value (0,73) and for HER2 96% with κ value (0,91). CNB can provide reliable information in evaluation of ER, PR and HER2 status in an invasive breast carcinoma.

Keywords

References

1.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J. ComberH at al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;1374–403.
2.
Christopher J, Cimino-Mathews A, Park B, Emens L, Tsangaris T, Argani P. Reflex Estrogen receptor/Progesteron receptor/Human epidermal growth factor receptor 2 (Er/PR/Her2) Analysis of Breast Cancers in Needle Core Biopsy Specimens Dramaticlly Increases Health Care Costs. Am Surg Pathol. 2015;939–47.
3.
Dekker T, Smit V, Hooijer G, Van De Vijver M, Mesker V. Tollenaar RAEM at al. Reliability of core needle biopsy for determining ER and HER2 status in breast cancer. Ann Oncol. 2012;1–7.
4.
Kentaro T, Sasano H, Ishida T, Takeda M, Amari M, Tamaki N. Comparison of core needle bipsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR, and HER 2 status for breast cancer patients. Cancer Sci. 2010;2074–9.
5.
Elston C, Ellis I. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;403–10.

Citation

Copyright

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Partners